NCT05616260View on ClinicalTrials.gov

Acetazolamide for Obstructive Sleep Apnea to Improve Heart Health

PHASE2RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

December 2, 2022

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Acetazolamide

Acetazolamide tablet (encapsulated)

DRUG

Placebo

Sugar capsule manufactured to match encapsulated Acetazolamide

DEVICE

Continuous Positive Airway Pressure

Standard CPAP device

Trial Locations (1)

92121

RECRUITING

UC San Diego; Altman Clinical and Translational Research Institute Building, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER